US Patent 11661424 Process for preparing BTK inhibitors
Patent 11661424 was granted and assigned to Genentech on May, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 May, 2023
Golden AI
Edits made to:
Infobox (+16 properties)
Article (+380 characters)
US Patent 11661424 Process for preparing BTK inhibitors
Article
Methods for preparing the Bruton's Tyrosine Kinase (“BTK”) inhibitor compound 2-{3′-hydroxymethyl-1-methyl-5-[5-((S)-2-methyl-4-oxetan-3-yl-piperazin-1-yl)-pyridin-2-ylamino]-6-oxo-1,6-dihydro-[3,4′]bipyridinyl-2′-yl}-7,7-dimethyl-3,4,7,8-tetrahydro-2H,6H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1-one are provided. Methods for preparing tricyclic lactam compounds are also provided.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116614240
Date of Patent
May 30, 2023
0Patent Application Number
171020860
Date Filed
November 23, 2020
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11661424 Process for preparing BTK inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
